Press Releases

Sign up for Email Alerts Press Release RSS

01/22/2018
European Commission Approves Bristol-Myers Squibb’s Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma
Term:Corporate/Financial News
Language:English
01/20/2018
Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer
Term:Corporate/Financial News
Language:English
01/03/2018
Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference
Term:Corporate/Financial News
Language:English

Business Wire NewsHQ^sm